Verana Health Delivers Powerful Update to RWD Bladder Cancer Database
New Release Continues Significant Expansion of Resources for Genitourinary Cancer Research
The bladder cancer database expansion follows recent significant investments in genitourinary cancer research by Verana Health, including the introduction of the world's largest curated RWD prostate cancer dataset and the industry's first end-to-end urologic-oncology datasets.
The American Cancer Society estimates over 84,500 people will be diagnosed with bladder cancer in the
"The impact of genitourinary cancers on patients is profound, with research showing significant reverberating effects on relatives and spouses," said
As the exclusive data and analytics partner of the American Urological Association (AUA) Quality (AQUA)® Registry, Verana Health transforms unstructured urology data from electronic health records (EHRs) into high-quality research-ready datasets through a sophisticated curation process leveraging AI and large language model (LLM) techniques.
The Verana Health bladder cancer database offers exclusive, real-world therapeutic insights and detailed understanding of the rapidly evolving treatment paradigms in both non-muscle and muscle invasive bladder cancers, through deep clinical data and critical elements such as T-stage, tumor focality, tumor grade, and tumor response.
The recently released prostate cancer dataset consists of data from participating urologists in the AQUA Registry and is bolstered by the recent COTA merger with Verana Health, which expanded the company's network access to more than 30 Academic Medical Centers and over 10 million accessible oncology patients.
Verana Health urologic-oncology datasets bring together longitudinal, specialty-spanning real-world data from urology and medical oncology practices to create an unparalleled comprehensive, granular view of the patient journey supporting life sciences organizations in evidence generation for regulatory submissions, market access, and commercialization decisions.
The bladder cancer database expansion coincides with the ASCO Annual Meeting, the world's largest and most prominent oncology conference, attracting over 44,000 oncology professionals for research, education, and networking to
Through an extensive partnership network, Verana can link disease-specific EHR data with other sources including genomics, medical claims, pharmaceutical claims, and images for a deeper understanding of the full patient journey.
About Verana Health
Verana Health, Inc.® is a digital health company revolutionizing patient care and clinical research by utilizing physician expertise and artificial intelligence to unlock the true potential of real-world data. With exclusive access to the world's largest patient data sources in oncology, ophthalmology, neurology, and urology. Verana Health is powering real-world evidence generation. Clinicians utilize these insights to improve the quality of care and quality of life for patients, and life sciences companies rely on the insights to accelerate the development of new therapies. For more information, visit www.veranahealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/verana-health-delivers-powerful-update-to-rwd-bladder-cancer-database-302775326.html
SOURCE Verana Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Africa Tech Festival 2026 returns as Africa's defining platform for digital transformation, investment and innovation
- Built for the Future of Fast Casual: TOGO'S Sandwiches Taps Franchise FastLane to Expand its Next-Gen Concept
- Brent Leggs Unanimously Elected as the 11ᵗʰ President and CEO of the National Trust for Historic Preservation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share